Zealand Pharma A (CPSE:ZEAL) Price Target Decreased by 20.43% to 560.34

Average one-year price target for Zealand Pharma A (CPSE:ZEAL) was revised down to 560.34 kr/share, a 20.43% decrease from the prior 704.21 kr estimate dated 2026-02-21. The drop in the consensus analyst target signals materially lower expectations and is likely to pressure near-term investor sentiment and the stock price.

Analysis

Average one-year price target for Zealand Pharma A (CPSE:ZEAL) was revised down to 560.34 kr/share, a 20.43% decrease from the prior 704.21 kr estimate dated 2026-02-21. The drop in the consensus analyst target signals materially lower expectations and is likely to pressure near-term investor sentiment and the stock price.